FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-191-03 | KVK-Tech, Inc. | ANDA209037 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-191-10 | KVK-Tech, Inc. | ANDA209037 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-191-50 | KVK-Tech, Inc. | ANDA209037 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-192-01 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-192-03 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-192-10 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-192-50 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 10702-193-01 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 10702-193-03 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 10702-193-10 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 10702-193-50 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-194-01 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-194-03 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-194-10 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 10702-194-50 | KVK-Tech, Inc. | ANDA209036 | HUMAN PRESCRIPTION DRUG | ANDA |
OXYCODONE HYDROCHLORIDE; ACETAMINOPHEN | 10702-238-50 | KVK-Tech, Inc. | ANDA211499 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; CAFFEINE; ACETAMINOPHEN | 10702-253-01 | KVK-Tech, Inc. | ANDA211106 | HUMAN PRESCRIPTION DRUG | ANDA |
BUTALBITAL; CAFFEINE; ACETAMINOPHEN | 10702-253-50 | KVK-Tech, Inc. | ANDA211106 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | 10702-340-01 | KVK-Tech, Inc. | NDA208653 | HUMAN PRESCRIPTION DRUG | NDA |
BENZHYDROCODONE HYDROCHLORIDE; ACETAMINOPHEN | 10702-341-01 | KVK-Tech, Inc. | NDA208653 | HUMAN PRESCRIPTION DRUG | NDA |
BENZHYDROCODONE HYDROCHLORIDE; ACETAMINOPHEN | 10702-342-01 | KVK-Tech, Inc. | NDA208653 | HUMAN PRESCRIPTION DRUG | NDA |
BENZHYDROCODONE HYDROCHLORIDE; ACETAMINOPHEN | 10702-343-01 | KVK-Tech, Inc. | NDA208653 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
BENZHYDROCODONE HYDROCHLORIDE; ACETAMINOPHEN | 10702-344-01 | KVK-Tech, Inc. | NDA208653 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE | 10702-345-01 | KVK-Tech, Inc. | NDA208653 | HUMAN PRESCRIPTION DRUG | NDA authorized generic |
ACETAMINOPHEN | 10956-762-01 | REESE PHARMACEUTICAL CO. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 10956-762-25 | REESE PHARMACEUTICAL CO. | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 10956-762-50 | REESE PHARMACEUTICAL CO. | part343 | HUMAN OTC DRUG | OTC monograph not final |
PHENYLEPHRINE HYDROCHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN | 10956-812-01 | REESE PHARMACEUTICAL CO. | part341 | HUMAN OTC DRUG | OTC monograph final |
PHENYLEPHRINE HYDROCHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN | 10956-812-30 | REESE PHARMACEUTICAL CO. | part341 | HUMAN OTC DRUG | OTC monograph final |
PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE | 10956-813-01 | REESE PHARMACEUTICAL CO. | part341 | HUMAN OTC DRUG | OTC monograph final |
-